High abundance and diversity of antimicrobial resistance determinants among early vancomycin-resistant Enterococcus faecium in Poland

被引:0
|
作者
E. Sadowy
A. Sieńko
I. Gawryszewska
A. Bojarska
K. Malinowska
W. Hryniewicz
机构
[1] National Medicines Institute,Department of Molecular Microbiology
[2] Epidemiological Response Centre of the Polish Armed Forces,Department of Epidemiology and Clinical Microbiology
[3] National Medicines Institute,undefined
关键词
Linezolid; Teicoplanin; Daptomycin; Tigecycline; Resistance Determinant;
D O I
暂无
中图分类号
学科分类号
摘要
The purpose of this study was to investigate the clonal structure, antimicrobial resistance phenotypes and their determinants among early vancomycin-resistant Enterococcus faecium (VREm) isolates in Poland. Two hundred and eighty-one VREm isolates collected between 1997 and 2005 were studied. VREm isolates were characterised by multilocus sequence typing (MLST). The presence of antimicrobial resistance determinants, transposon-specific genes, IS16 and espEfm was checked by polymerase chain reaction (PCR). Ciprofloxacin and ampicillin resistance determinants were investigated by sequencing. Two hundred and twenty-two (79 %) and 59 (21 %) VREm isolates were vanA- and vanB-positive, respectively. Among 135 representative isolates, MLST yielded 33 different sequence types (STs), of which 29 were characteristic of hospital-associated E. faecium; 128 (94.8 %) and 123 (91.1 %) isolates harboured the IS16 and espEfm genes, and all 135 isolates were resistant to ciprofloxacin and ampicillin. Resistance to tetracycline (71.1 % isolates) was mostly associated with tetM (75.0 %) and the concomitant presence of the Tn916 integrase gene. High-level resistance to streptomycin (93.3 % of isolates) and high-level resistance to gentamicin (94.1 % of isolates) were due to ant(6′)-Ia and aac(6′)-Ie-aph(2″) genes, respectively, the latter of which is known to be located on various Tn4001-type transposons. Fifteen combinations of mutations in the quinolone-determining regions of GyrA and ParC were identified, including changes not previously reported, such as S83F and A84P in GyrA. Twenty-three variants of the penicillin-binding protein PBP5 occurred in the studied group, and novel insertions at amino acid positions 433 and 568 were identified. This analysis revealed the predominance of hospital-associated strains of E. faecium, carrying an abundant and divergent range of resistance determinants among early VREm isolates in Poland.
引用
收藏
页码:1193 / 1203
页数:10
相关论文
共 50 条
  • [21] Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faecium
    Rand, Kenneth H.
    Houck, Herbert J.
    Silverman, Jared A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (05) : 1017 - 1020
  • [22] Linezolid Resistance in Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolates in a Brazilian Hospital
    de Almeida, Lara M.
    de Araujo, Maria Rita E.
    Iwasaki, Marta F.
    Sacramento, Andrey G.
    Rocha, Darlan
    da Silva, Leila P.
    Pavez, Monica
    de Brito, Artemir C.
    Ito, Lais Carolina S.
    Gales, Ana C.
    Lincopan, Nilton
    Sampaio, Jorge L. M.
    Mamizuka, Elsa M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (05) : 2993 - 2994
  • [23] Outbreak of vancomycin-resistant Enterococcus faecium of the phenotype VanB in a hospital in Warsaw, Poland:: Probable transmission of the resistance determinants into an endemic vancomycin-susceptible strain
    Kawalec, M
    Gniadkowski, M
    Zaleska, M
    Ozorowski, T
    Konopka, L
    Hryniewicz, W
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (05) : 1781 - 1787
  • [24] Consideration of within-patient diversity highlights transmission pathways and antimicrobial resistance gene variability in vancomycin-resistant Enterococcus faecium
    McHugh, Martin P.
    Pettigrew, Kerry A.
    Taori, Surabhi
    Evans, Thomas J.
    Leanord, Alistair
    Gillespie, Stephen H.
    Templeton, Kate E.
    Holden, Matthew T. G.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (03) : 656 - 668
  • [25] Limiting vancomycin use to combat vancomycin-resistant Enterococcus faecium
    Belliveau, PP
    Rothman, AL
    Maday, CE
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (13) : 1570 - 1575
  • [26] Determinants of the clinical significance of blood culture isolates of vancomycin-resistant Enterococcus faecium
    Linden, PK
    Kramer, DJ
    Kusne, S
    CRITICAL CARE MEDICINE, 1999, 27 (12) : A117 - A117
  • [27] The rise in vancomycin-resistant Enterococcus faecium in Germany: data from the German Antimicrobial Resistance Surveillance (ARS)
    Markwart, Robby
    Willrich, Niklas
    Haller, Sebastian
    Noll, Ines
    Koppe, Uwe
    Werner, Guido
    Eckmanns, Tim
    Reuss, Annicka
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2019, 8 (01)
  • [28] The rise in vancomycin-resistant Enterococcus faecium in Germany: data from the German Antimicrobial Resistance Surveillance (ARS)
    Robby Markwart
    Niklas Willrich
    Sebastian Haller
    Ines Noll
    Uwe Koppe
    Guido Werner
    Tim Eckmanns
    Annicka Reuss
    Antimicrobial Resistance & Infection Control, 8
  • [29] Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
    Gonzales, RD
    Schreckenberger, PC
    Graham, MB
    Kelkar, S
    DenBesten, K
    Quinn, JP
    LANCET, 2001, 357 (9263): : 1179 - 1179
  • [30] Collateral sensitivity to pleuromutilins in vancomycin-resistant Enterococcus faecium
    Li, Qian
    Chen, Shang
    Zhu, Kui
    Huang, Xiaoluo
    Huang, Yucheng
    Shen, Zhangqi
    Ding, Shuangyang
    Gu, Danxia
    Yang, Qiwen
    Sun, Hongli
    Hu, Fupin
    Wang, Hui
    Cai, Jiachang
    Ma, Bing
    Zhang, Rong
    Shen, Jianzhong
    NATURE COMMUNICATIONS, 2022, 13 (01)